(Q37916396)

25 August 2017

1 reference

title

Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review (English)

1 reference

25 August 2017

Umberto Malapelle

1

1 reference

25 August 2017

Claudio Bellevicine

2

1 reference

25 August 2017

Pio Zeppa

3

1 reference

25 August 2017

Lucio Palombini

4

1 reference

25 August 2017

Giancarlo Troncone

5

1 reference

25 August 2017

publication date

9 November 2010

1 reference

25 August 2017

published in

Diagnostic Cytopathology

1 reference

25 August 2017

volume

39

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

703-710

1 reference

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies

25 August 2017

cites work

1 reference

Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions

21 January 2018

1 reference

EGFR antagonists in cancer treatment

21 January 2018

1 reference

Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making

21 January 2018

1 reference

Oncogenic mutations as predictive factors in colorectal cancer

21 January 2018

1 reference

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

21 January 2018

1 reference

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer

21 January 2018

1 reference

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.

21 January 2018

1 reference

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression

21 January 2018

1 reference

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

21 January 2018

1 reference

The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLC.

21 January 2018

1 reference

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

21 January 2018

1 reference

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

21 January 2018

1 reference

Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.

21 January 2018

1 reference

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers

21 January 2018

1 reference

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells

21 January 2018

1 reference

EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance

21 January 2018

1 reference

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening

21 January 2018

1 reference

Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis

21 January 2018

1 reference

Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis

21 January 2018

1 reference

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.

21 January 2018

1 reference

KRAS mutations and susceptibility to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

21 January 2018

1 reference

Metastasis of colon cancer to the thyroid gland: a case diagnosed on fine-needle aspirate by a combined cytological, immunocytochemical, and molecular approach.

21 January 2018

1 reference

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue

21 January 2018

1 reference

A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: a morphology-based approach in colorectal carcinoma

21 January 2018

1 reference

KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.

21 January 2018

1 reference

The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.

21 January 2018

1 reference

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics

21 January 2018

1 reference

K-ras mutations and cetuximab in colorectal cancer.

21 January 2018

1 reference

KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology

21 January 2018

1 reference

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting

21 January 2018

1 reference

Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.

21 January 2018

1 reference

Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations.

21 January 2018

1 reference

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

21 January 2018

1 reference

Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma

21 January 2018

1 reference

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

21 January 2018

1 reference

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

21 January 2018

1 reference

7 January 2021

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

1 reference

7 January 2021

KRAS mutation analysis on cytological specimens of metastatic colo-rectal cancer

1 reference

7 January 2021

Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer

1 reference

7 January 2021

BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status

1 reference

7 January 2021

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice

1 reference

7 January 2021

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer

1 reference

7 January 2021

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis

1 reference

7 January 2021

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases

1 reference

7 January 2021

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis

1 reference

7 January 2021

Pathologist and molecular biologist, ever the twain shall meet?

1 reference

7 January 2021

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens

1 reference

7 January 2021

Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.21512

1 reference

25 August 2017

1 reference